Exploring the antihyperglycemic potential of tetrapeptides devised from AdMc1 via different receptor proteins inhibition using in silico approaches.
Ghulam MustafaHafiza S MahroshMuddassar ZafarSyed A AttiqueRawaba ArifPublished in: International journal of immunopathology and pharmacology (2022)
In the light of overall results of all analyses employed in this study, the selected ligands could be further processed as potential hypoglycaemic drug candidates.